Management of early gastrointestinal neuroendocrine neoplasms

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

516

HTML

4462

Figures (1-1)

208

Tables (1-7)

279

Sum=5465

Jul 16, 2011 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Endosc. Jul 16, 2011; 3(7): 133-139
Published online Jul 16, 2011. doi: 10.4253/wjge.v3.i7.133

Table 2 Grading of gastrointestinal neuroendocrine neoplasms according to proliferative activity^a

^aModified according to reference[4,5,19];

^bMIB1 antibody, % of 100 tumor cells in areas of highest nuclear labeling.

Citation: Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G. Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc 2011; 3(7): 133-139
URL: https://www.wjgnet.com/1948-5190/full/v3/i7/133.htm
DOI: https://dx.doi.org/10.4253/wjge.v3.i7.133